Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

View From ICAAC: How Higher Prices Can Help Save Antibiotic R&D

17 Sep 2012

• By Emily Hayes

Related Content

With GAIN In Place, Antibiotic Improvements Depend On FDA Implementation

13 Aug 2012

Will New Antibiotic Incentives GAIN Investors’ Backing?

13 Aug 2012

Getting the Bugs Out of Antibiotic R&D: Commercial Implications of a Higher Regulatory Hurdle

01 Jun 2007

Antibiotic Policy Solutions An Ocean Apart Between U.S., EU

24 May 2012

Panel Gives Mixed Reviews To Using Single Trial For Community-Acquired Pneumonia

14 Nov 2011

Related Companies

Pfizer Inc.

Cubist Pharmaceuticals, Inc.

GSK plc

MedImmune LLC

Sanofi

AstraZeneca PLC

Johnson & Johnson

Basilea Pharmaceutica Ltd.

Additional Topics

Clinical Trials Drug Approval Standards BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.